Join us and guests as we seek to understand how bias has undermined clinical trials and impeded disease prevention and treatment and explore how sponsors, patients, and investigators have overcome historic biases to conduct more equitable clinical trials.

Featuring panelists from the Emerson Clinical Research Institute and the Yale Center for Clinical Investigation.

 

Register Now

Missed the live webinar? You can also register to view the recording on demand.

 

Abstract:

How do we unpack the full meaning of patient diversity in clinical trials?  The lack of equity and representation of minority groups in biomedical research has been an open concern for many years despite regulatory and private-sector initiatives.  Now, there is reason to hope for significant change, spurred by heightened awareness of racial discrimination in US healthcare and COVID-19's disproportionate toll on disadvantaged communities.  But how do we strike the correct balance of scientific and ethical imperatives as we capitalize on this opportunity? Can we secure a commitment from internal and external stakeholders? And what form should that commitment take? In this panel-led discussion—the first of four in a new series—Syneos Health will interrogate whether and how 12 months of global pandemic might illuminate a new path to equitable and inclusive clinical research.  

 

Moderator:

Stephen Keith, MD

  • Over 25 years of experience in biopharma industry in vaccines development (e.g. influenza Type B, meningococcal, pneumococcal, and Group B Strep.  as well as  diphtheria, tetanus, pertussis, and inactivated polio vaccines).  Joined Syneos Health in 2018 as medical leader and also serves to support Patient Diversity initiatives.
  • Previously, held C-level positions at 3 biotech companies, and was a General Partner in a life sciences venture capital organization.
  • Prior to entering the pharmaceutical industry, served as Health Policy Advisor to the U.S. Senate Committee on Labor and Human Resources, under Senator Edward M. Kennedy.
  • MD Pediatrician by training /practice, and RW Johnson Clinical Scholar at UCLA with qualifications in Public Health.  Faculty member at the Charles Drew Medical School & UCLA School of Medicine (Pediatrics).  Fellow of the Academy of Pediatrics, and Diplomate of the American Board of Pediatrics.
  • Board of Directors of National Medical Fellowships, and Community Health Charities.

 

When 
Wed, Jan 27, 01:00 pm to 02:00 pm
Additional Details